2022 regulatory trends in China, including data protection, TMT, capital markets, PE/VC, IP, dispute resolution, healthcare, banking & finance, sanctions and antitrust.
Charles Wu and Zaiguang Lu of Han Kun Law Offices review the significant legislative developments of 2022 affecting China's private equity and venture capital industry, and offer insights into the key trends, challenges and opportunities in the sector
Geoffrey Chan, Sophie Xue, and Nicholas Poon of Skadden, Arps, Slate, Meagher & Flom examine how the Hong Kong Limited Partnership Fund, which serves as a cost and tax efficient vehicle for private equity transactions, could become a popular alternative to traditional offshore fund structures for PE investments and fundraising in Greater China
New social credit draft law raises concerns for foreign companies; CSRC lifts ban on property M&A and refinancing; and U.K. government unwinds a completed transaction for the first time.
In the second part of this series, Ivan Jin, Allen Liu, Bella Cao and Huppert Hu of Merits & Tree Law Offices look at the ever-expanding opportunities for cooperation between insurance companies and foreign investors amidst a complex regulatory landscape
In the first part of a two-part series, Ivan Jin, Allen Liu, Bella Cao and Huppert Hu of Merits & Tree Law Offices explain how foreign capital and Chinese insurance funds can aim to "dance with harmony" in China's private equity market, as they navigate multiple regulatory and practical challenges
SAMR issues 28 administrative penalties for failing to disclose M&A deals; CAC clarifies details about data export security assessment; banks and insurance companies to support advanced manufacturing
EU Commission releases guidance on updated standard clauses for GDPR-regulated parties; Xiaohongshu invests in US-based Web3 startup; Regulations on price labelling and price gouging
